Arutha Kulasinghe
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in ⓘ
-
- Cancer Genomics and Diagnostics 36
- Oncology 68
- Cancer Cells and Metastasis 39
- Cancer Immunotherapy and Biomarkers 31
- CAR-T cell therapy research 7
- Co-authors
- Kenneth J. O’Byrne (50 shared papers)Chamindie Punyadeera (33 shared papers)Majid Ebrahimi Warkiani (37 shared papers)Rahul Ladwa (22 shared papers)Liz Kenny (19 shared papers)Habib Sadeghirad (14 shared papers)Yavar Shiravand (3 shared papers)Seyed Reza Hosseini‐Fard (2 shared papers)
- Journals
- Clinical & Translational Immunology (7 papers)Frontiers in Oncology (6 papers)Frontiers in Immunology (5 papers)Journal of Translational Medicine (4 papers)Cancer Research (4 papers)
- Partner nations
- AustraliaUnited StatesRussia
In The Last Decade
Arutha Kulasinghe
88 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 933
- Oncology 1.7k
- Immunology 637
- Otorhinolaryngology 115
- Pulmonary and Respiratory Medicine 607
Countries citing papers authored by Arutha Kulasinghe
This map shows the geographic impact of Arutha Kulasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arutha Kulasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arutha Kulasinghe more than expected).
Fields of papers citing papers by Arutha Kulasinghe
This network shows the impact of papers produced by Arutha Kulasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arutha Kulasinghe. The network helps show where Arutha Kulasinghe may publish in the future.
Co-authors
The 25 scholars most cited alongside Arutha Kulasinghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibitors in Cancer Therapy Hit paper breakdown → | 2022 | 721 |
| 2 | 2020 | 222 | |
| 3 | 2019 | 182 | |
| 4 | 2019 | 155 | |
| 5 | 2021 | 102 | |
| 6 | 2021 | 92 | |
| 7 | 2018 | 88 | |
| 8 | 2018 | 87 | |
| 9 | 2014 | 84 | |
| 10 | 2017 | 71 | |
| 11 | 2019 | 71 | |
| 12 | 2017 | 61 | |
| 13 | 2020 | 53 | |
| 14 | 2018 | 52 | |
| 15 | 2018 | 51 | |
| 16 | 2021 | 48 | |
| 17 | 2016 | 47 | |
| 18 | 2015 | 42 | |
| 19 | 2016 | 38 | |
| 20 | 2016 | 38 |
About Arutha Kulasinghe
Arutha Kulasinghe is a scholar working on Cancer Research, Oncology, Immunology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (39 papers), Cancer Genomics and Diagnostics (36 papers), Cancer Immunotherapy and Biomarkers (31 papers), Immune cells in cancer (17 papers), Single-cell and spatial transcriptomics (16 papers), Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and Extracellular vesicles in disease (7 papers). The work is most often cited by research in Cancer Research (933 citations), Oncology (1.7k citations), Immunology (637 citations), Otorhinolaryngology (115 citations) and Pulmonary and Respiratory Medicine (607 citations). Arutha Kulasinghe has collaborated with scholars based in Australia, United States and Russia. Frequent co-authors include Kenneth J. O’Byrne, Chamindie Punyadeera, Majid Ebrahimi Warkiani, Rahul Ladwa, Liz Kenny, Habib Sadeghirad, Yavar Shiravand, Seyed Reza Hosseini‐Fard, Shadi Hosseini and Faezeh Khodadadi. Their work appears in journals such as Clinical & Translational Immunology, Frontiers in Oncology, Frontiers in Immunology, Journal of Translational Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.